Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Sales | 15,035 | 13,995 | 12,355 | 17,039 | 13,489 |
| Cost of Goods | 7,262 | 7,995 | 7,272 | 6,617 | 7,428 |
| Gross Profit | 7,773 | 6,000 | 5,083 | 10,422 | 6,061 |
| Operating Expenses | 7,850 | 7,522 | 7,362 | 6,540 | 5,757 |
| Operating Income | 185 | -527 | -2,007 | 4,499 | 732 |
| Other Income | 70 | 75 | 42 | 19 | 7 |
| Pre-tax Income | 255 | -452 | -1,965 | 4,518 | 739 |
| Income Tax | 18 | 14 | -130 | 23 | 11 |
| Net Income Continuous | 237 | -466 | -1,835 | 4,495 | 728 |
| Minority Interests | -31 | -30 | N/A | N/A | N/A |
| Net Income | $268 | $-436 | $-1,835 | $4,495 | $728 |
| EPS Basic Total Ops | 0.02 | -0.03 | -0.14 | 0.33 | 0.05 |
| EPS Basic Continuous Ops | 0.02 | -0.03 | -0.13 | 0.33 | 0.05 |
| EPS Diluted Total Ops | 0.02 | -0.03 | -0.12 | 0.31 | 0.05 |
| EPS Diluted Continuous Ops | 0.02 | -0.03 | -0.13 | 0.31 | 0.05 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.03 | -0.13 | 0.31 | 0.05 |
| EBITDA(a) | $542 | $-169 | $-1,613 | $4,897 | $1,131 |